Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Bora has announced the appointment of four business development directors to its commercial teams in the US and Taiwan.
read more
Wednesday, February 11, 2015
Boehringer Ingelheim, a research-based, global pharmaceutical company, and VTU Technology, a leading contract research and development company, announced today the renewal of their global Pichia pastoris technology collaboration agreement. VTU ...
read more
Boehringer Ingelheim has signed with Zhangjiang Biotech & Pharmaceutical Base Development Company in Pudong, Shanghai a strategic alliance agreement and contract to build a cGMP biopharmaceuticals facility. The new site will provide full range of ...
read more
Tuesday, November 11, 2014
Boehringer Ingelheim, one of the top 20 global pharma companies, has introduced IDBS’ [2]E-WorkBook Suite to eliminate data silos in the lab. The cross-domain platform has initially been deployed in North America with the next roll-out planned for ...
read more
Tuesday, October 31, 2017
Boehringer Ingelheim and Sarah Cannon Research Institute announced an expansion of their partnership to develop novel immuno-oncology therapies
read more
Boehringer Ingelheim announced today an agreement with Servier and its partner XOMA Corporation (Nasdaq: XOMA) to transfer XOMA’s technology and process for the commercial manufacture of gevokizumab, XOMA’s novel interleukin 1-beta (IL-1ß) allosteric...
read more
Tuesday, February 21, 2012
Xencor, Inc., a company using its proprietary Protein Design Automation® (PDA) platform technology to engineer next-generation antibodies, and Boehringer Ingelheim announced today a collaboration agreement for certain Xencor biosuperior monoclonal ...
read more
Thursday, August 23, 2018
bluebird bio and Gritstone Oncology announced a collaboration to research, develop and commercialize products for the treatment of cancer using cell therapy.
read more
Wednesday, November 29, 2017
bluebird bio has acquired a 125,000-square foot manufacturing facility in Durham, North Carolina.
read more
Blue Water Vaccines has signed an agreement with Ology Bioservices to manufacture a novel universal influenza vaccine.
read more
Thursday, November 18, 2021
BiVictriX Therapeutics plc, an emerging biotechnology company applying a novel approach to develop next generation cancer therapies using insights derived from frontline clinical experience is pleased to announce a collaboration to manufacture ...
read more
Thursday, December 14, 2017
BioVectra announced a long-term supply agreement with Keryx Biopharmaceuticals to manufacture Ferric Citrate.
read more
BIOVECTRA has broken ground on a cutting-edge facility that will manufacture mRNA vaccines and therapeutics starting in 2023.
read more
Thursday, November 18, 2021
BIOVECTRA has announced plans for the development of a state-of-the-art facility specializing in the production and manufacturing of mRNA vaccines and therapeutics – one of the first of its kind in Canada.
read more
BioVectra announced a five-year, $144.6 million (CAD) expansion project to enhance its Biopharmaceutical capabilities in both Charlottetown, Prince Edward Island and Windsor, Nova Scotia.
read more